These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19141525)

  • 1. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets.
    Luna CM; Bruno DA; García-Morato J; Mann KC; Risso Patrón J; Sagardía J; Absi R; García Bottino M; Marchetti D; Famiglietti A; Baleztena M; Biancolini C
    Chest; 2009 Jun; 135(6):1564-1571. PubMed ID: 19141525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
    Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A
    Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
    Wunderink RG; Mendelson MH; Somero MS; Fabian TC; May AK; Bhattacharyya H; Leeper KV; Solomkin JS
    Chest; 2008 Dec; 134(6):1200-1207. PubMed ID: 18719064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection.
    Yanagihara K; Kihara R; Araki N; Morinaga Y; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Tsukamoto K; Kamihira S
    Int J Antimicrob Agents; 2009 Nov; 34(5):477-81. PubMed ID: 19665359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia?
    Akinnusi ME; Hattemer A; Gao W; El-Solh AA
    Crit Care Med; 2011 Aug; 39(8):1944-52. PubMed ID: 21532475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
    Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
    J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.
    Jacqueline C; Broquet A; Roquilly A; Davieau M; Caillon J; Altare F; Potel G; Asehnoune K
    J Infect Dis; 2014 Sep; 210(5):814-23. PubMed ID: 24620024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.
    Yoshizawa S; Tateda K; Saga T; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1744-8. PubMed ID: 22290944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
    Tessier PR; Keel RA; Hagihara M; Crandon JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 May; 56(5):2342-6. PubMed ID: 22354302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study.
    Watanabe A; Goto H; Soma K; Kikuchi T; Gomi K; Miki H; Maemondo M; Ikeda H; Kuroki J; Wada H; Yokoyama T; Izumi S; Mitsutake K; Ueda Y
    J Infect Chemother; 2012 Apr; 18(2):160-8. PubMed ID: 22041987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
    Lepak AJ; Marchillo K; Pichereau S; Craig WA; Andes DR
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5916-22. PubMed ID: 22964254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
    J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
    Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
    Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
    Bhan U; Podsiad AB; Kovach MA; Ballinger MN; Keshamouni V; Standiford TJ
    PLoS One; 2015; 10(1):e0114574. PubMed ID: 25635685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.
    Fernández-Barat L; Ferrer M; Sierra JM; Soy D; Guerrero L; Vila J; Li Bassi G; Cortadellas N; Martínez-Olondris P; Rigol M; Esperatti M; Luque N; Saucedo LM; Agustí C; Torres A
    Crit Care Med; 2012 Aug; 40(8):2385-9. PubMed ID: 22622402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
    Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
    J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.